Marilyn MacKay-Lyons1,2, Gordon Gubitz3, Stephen Phillips3, Nicholas Giacomantonio4,5, Wanda Firth5, Kara Thompson6, Chris Theriault6, Howard Wightman7, Sharon Slipp8, David Marsters9, Gail Eskes10,11,12, Fiona Peacock13, Chris Blanchard12, Judy Dewolfe13. 1. School of Physiotherapy, 3688Dalhousie University, Halifax, NS, Canada. 2. Physical Medicine, Nova Scotia Health Authority, 3688Dalhousie University, Halifax, NS, Canada. 3. Neurology, 3688Dalhousie University, Halifax, NS, Canada. 4. 12361QEII Health Sciences Centre, Halifax, NS, Canada. 5. Cardiac Rehabilitation, QEII Community Cardiovascular Hearts-in-Motion, Halifax, NS, Canada. 6. Nova Scotia Health, Research Methods Unit, Halifax, NS, Canada. 7. Cardiology Associates, Valley Regional Hospital, Kentville, NS, Canada. 8. Cardiac Rehabilitation, Valley Regional Hospital, Kentville, NS, Canada. 9. Internal Medicine, Valley Regional Hospital, Kentville, NS, Canada. 10. Physical Medicine, Nova Scotia Health Authority, Halifax, NS, Canada. 11. Psychiatry, 3688Dalhousie University, Halifax, NS, Canada. 12. Medicine, Nova Scotia Health, Halifax, NS, Canada. 13. Cardiac Specialty Clinic, Valley Regional Hospital, Kentville, Canada.
Abstract
BACKGROUND: Non-disabling stroke (NDS) and transient ischemic attack (TIA) herald the possibility of future, more debilitating vascular events. Evidence is conflicting about potency of exercise and education in reducing risk factors for second stroke. METHODS: Three-site, single-blinded, randomized controlled trial with 184 participants <3 months of NDS or TIA (mean age, 65 years; 66% male) randomized to usual care (UC) or UC + 12-week program of exercise and education (PREVENT). Primary (resting systolic blood pressure) and secondary outcomes (diastolic blood pressure [DBPrest], high-density lipoprotein cholesterol [HDL-C], low-density lipoprotein cholesterol [LDL-C], total cholesterol [TC], TC/HDL, triglycerides, fasting glucose, and body mass index) were assessed at baseline, post-intervention, and 6- and 12-month follow-up. Peak oxygen consumption (VO2peak) was measured at baseline, post-intervention, 12-month assessments. RESULTS: Significant between-group differences at post-intervention favored PREVENT group over UC: DBPrest (mean difference [MD]: -3.2 mmHg, 95% confidence interval [CI]: -6.3, -.2, P = .04) and LDL-C (MD: -.31 mmol/L, 95% CI: -.42, -.20, P = .02). Trends of improvement in PREVENT group were noted in several variables between baseline and 6-month follow-up but not sustained at 12-month follow-up. Of note, VO2 peak did not change over time in either group. CONCLUSION: Impact of PREVENT on vascular risk factor reduction was more modest than anticipated, possibly because several outcome variables approximated normative values at baseline and training intensity may have been sub-optimal. Further investigation is warranted to determine when exercise and education programs are viable adjuncts to pharmaceutical management for reduction of risk factors for second stroke.Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: #NCT00885456.
BACKGROUND: Non-disabling stroke (NDS) and transient ischemic attack (TIA) herald the possibility of future, more debilitating vascular events. Evidence is conflicting about potency of exercise and education in reducing risk factors for second stroke. METHODS: Three-site, single-blinded, randomized controlled trial with 184 participants <3 months of NDS or TIA (mean age, 65 years; 66% male) randomized to usual care (UC) or UC + 12-week program of exercise and education (PREVENT). Primary (resting systolic blood pressure) and secondary outcomes (diastolic blood pressure [DBPrest], high-density lipoprotein cholesterol [HDL-C], low-density lipoprotein cholesterol [LDL-C], total cholesterol [TC], TC/HDL, triglycerides, fasting glucose, and body mass index) were assessed at baseline, post-intervention, and 6- and 12-month follow-up. Peak oxygen consumption (VO2peak) was measured at baseline, post-intervention, 12-month assessments. RESULTS: Significant between-group differences at post-intervention favored PREVENT group over UC: DBPrest (mean difference [MD]: -3.2 mmHg, 95% confidence interval [CI]: -6.3, -.2, P = .04) and LDL-C (MD: -.31 mmol/L, 95% CI: -.42, -.20, P = .02). Trends of improvement in PREVENT group were noted in several variables between baseline and 6-month follow-up but not sustained at 12-month follow-up. Of note, VO2 peak did not change over time in either group. CONCLUSION: Impact of PREVENT on vascular risk factor reduction was more modest than anticipated, possibly because several outcome variables approximated normative values at baseline and training intensity may have been sub-optimal. Further investigation is warranted to determine when exercise and education programs are viable adjuncts to pharmaceutical management for reduction of risk factors for second stroke.Clinical Trial Registration-URL: http://www.clinicaltrials.gov. Unique identifier: #NCT00885456.
Authors: Judith M Lam; Christoph Globas; Joachim Cerny; Benjamin Hertler; Kamil Uludag; Larry W Forrester; Richard F Macko; Daniel F Hanley; Clemens Becker; Andreas R Luft Journal: Neurorehabil Neural Repair Date: 2010-05-07 Impact factor: 3.919
Authors: Gregory W Albers; Louis R Caplan; J Donald Easton; Pierre B Fayad; J P Mohr; Jeffrey L Saver; David G Sherman Journal: N Engl J Med Date: 2002-11-21 Impact factor: 91.245
Authors: James H Rimmer; Amy E Rauworth; Edward C Wang; Terry L Nicola; Bernadette Hill Journal: Arch Phys Med Rehabil Date: 2009-03 Impact factor: 3.966
Authors: David A Brenner; Rich M Zweifler; Camilo R Gomez; Brett M Kissela; Deborah Levine; George Howard; Bruce Coull; Virginia J Howard Journal: J Stroke Cerebrovasc Dis Date: 2010-05-15 Impact factor: 2.136
Authors: Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow Journal: J Am Geriatr Soc Date: 2005-04 Impact factor: 5.562
Authors: Neil Heron; Frank Kee; Christopher Cardwell; Mark A Tully; Michael Donnelly; Margaret E Cupples Journal: Br J Gen Pract Date: 2016-12-05 Impact factor: 5.386